Komori
KYORIN Pharmaceutical (4569) · Initiative¥1,315 million in shares scheduled for delivery

Employee Shareholding Incentives and Share Delivery Plan

First written in FY2017. 1 of 5 entries say "Restated". Latest entry: FY2026.

5entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY2019ReframedFY20242017: 120172018: 120182019: 120192020: 020202021: 020212022: 020222023: 020232024: 120242025: 020252026: 12026
Same theme, other companies
Combined use of a trust-based employee stock ownership incentive plan and J-ESOPA theme 2 companies write about · 0 as a headwind · 2 as a tailwind

0 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026¥1,315 million in shares scheduled for deliveryAnnual report

    「Total value of shares scheduled to be granted to employees: ¥1,315 million」

    J-ESOP remains in place, but the total value of shares scheduled to be granted to employees changed from ¥1,322 million in the previous disclosure to ¥1,315 million.
  2. FY2024ReframedAnnual report

    「The Company has introduced a share-based benefit trust (J-ESOP) to reflect employees' roles, contributions and performance in their compensation and to increase their motivation to work, sense of belonging and corporate value through the provision of Company shares and cash.」

    Separately from the former trust-based employee shareholding incentive plan, which ended in August 2018, the employee share benefit plan under J-ESOP remains in place. The disclosed total value of shares scheduled to be granted was ¥1,322 million.
  3. FY2019DroppedAnnual report

    「The Company had introduced the trust-based employee shareholding incentive plan (the “Plan”), but the Plan ended in August 2018.」

    The employee shareholding incentive plan ended in August 2018, while J-ESOP remains in place.
  4. FY2018RestatedAnnual report

    「Total value of shares scheduled to be acquired by the employee shareholding association: ¥240 million」

    The employee shareholding incentive plan remains in place, and the Company disclosed a total scheduled share value of ¥240 million.
  5. FY2017First statedAnnual report

    「We have introduced a “trust-type employee shareholding incentive plan” to enhance employee benefits and raise employees’ awareness of the share price and their motivation to work, thereby enhancing corporate value, by steadily supplying Company shares to the employee shareholding association and distributing to employees the income earned from managing the trust assets.」

    The trust-type employee shareholding incentive plan is disclosed as a measure to enhance benefits, share-price awareness, employee motivation and corporate value.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Employee Shareholding Incentives and Share Delivery Plan | KYORIN Pharmaceutical Co.,Ltd. (4569) | Komori